Saturday, October 3, 2026

USD/EUR Over 1% Down In The Last 10 Sessions

USD/EUR Over 1% Down In The Last 10 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.12% for the last 10 sessions. At 08:07 EST on Wednesday, 10 July, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 4.127% up from its 52-week low and 3.501% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.17%, a negative 0.02%, and a positive 0.26%, respectively.

USD/EUR's highest amplitude of average volatility was 0.21% (last week), 0.24% (last month), and 0.26% (last quarter), respectively.

News about

  • Usd/jpy price analysis: struggles at key resistance, slumps below 161.00. According to FXStreet on Monday, 8 July, "If USD/JPY buyers reclaim 161.00, that could exacerbate an upward move toward the year-to-date (YTD) high of 161.95. ", "The USD/JPY daily chart is set to continue to trend higher from a price action standpoint, but fears of intervention by Japanese authorities in the FX markets might dent buyers from pushing the exchange rate higher."
  • According to FXStreet on Tuesday, 9 July, "The USD/JPY pair could test the key resistance at the upper boundary of the ascending channel near the level of 162.55. ", "On the downside, the USD/JPY pair may find immediate support around the 21-day Exponential Moving Average (EMA) at 159.78. "
  • According to FXStreet on Tuesday, 9 July, "Extra recovery in the US Dollar and the move higher in yields underpinned the daily uptick in USD/JPY to three-day highs near 161.50. "
  • Usd/jpy price analysis: rises past 161.00 as powell stays cautious. According to FXStreet on Tuesday, 9 July, "The USD/JPY pair's uptrend is robust, with buyers poised to surpass the year-to-date (YTD) high of 161.95. ", "If USD/JPY clears the psychological 161.50, the next resistance would be the YTD high ahead of 162.00. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com